Investigational Site Number 840-150 — Pearland, Texas

Investigational Site Number 840-150 is a clinical research site located in Pearland, Texas, United States 77584.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 840-150 has participated in 1 clinical trials.

Therapeutic areas: Type 1 Diabetes Mellitus.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pearland

Browse all research sites in Texas · View every site in Pearland

• The Methodist Hospital d/b/a HMRI CCAT at Pearland
• The Methodist Hospital
• Methodist Hospital Research Institute, Internal Medicine
• LinQ Research
• Research Site
• Advances In Health
• Texas Oncology-Gulf Coast
• Pearland Physicians
• GSK Investigational Site
• Research Site 32
• HCA Houston Healthcare Pearland
• Pfizer Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840-150?

Investigational Site Number 840-150 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840-150 conducted?

Investigational Site Number 840-150 has 1 clinical trials on record. Their work covers Type 1 Diabetes Mellitus.

Is Investigational Site Number 840-150 accredited by Crixeo Clinical Trials?

Investigational Site Number 840-150 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840-150?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.